Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,679 | 42 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,037 | 15 | $0 (2022) |
| Janssen Biotech, Inc. | $966.27 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $316.66 | 5 | $0 (2018) |
| PFIZER INC. | $231.96 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $204.12 | 2 | $0 (2022) |
| Gilead Sciences, Inc. | $125.00 | 1 | $0 (2020) |
| Phathom Pharmaceuticals, Inc. | $124.56 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $124.23 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $123.04 | 1 | $0 (2019) |
| Amgen Inc. | $120.06 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $801.08 | 6 | Janssen Biotech, Inc. ($583.74) |
| 2023 | $379.96 | 3 | Janssen Biotech, Inc. ($259.90) |
| 2022 | $438.18 | 7 | Janssen Pharmaceuticals, Inc ($223.55) |
| 2021 | $832.60 | 8 | Janssen Pharmaceuticals, Inc ($673.76) |
| 2020 | $125.00 | 1 | Gilead Sciences, Inc. ($125.00) |
| 2019 | $453.13 | 4 | PFIZER INC. ($231.96) |
| 2018 | $349.46 | 6 | E.R. Squibb & Sons, L.L.C. ($196.55) |
| 2017 | $299.11 | 7 | E.R. Squibb & Sons, L.L.C. ($120.11) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $149.05 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $92.78 | General |
| Category: VTE | ||||||
| 08/07/2024 | Janssen Biotech, Inc. | TALVEY (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $149.05 | General |
| Category: Oncology | ||||||
| 05/09/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $149.05 | General |
| Category: Oncology | ||||||
| 02/22/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $136.59 | General |
| Category: Oncology | ||||||
| 07/12/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $120.06 | General |
| Category: Cardiology | ||||||
| 06/07/2023 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $125.65 | General |
| Category: Oncology | ||||||
| 02/24/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $134.25 | General |
| Category: Oncology | ||||||
| 12/01/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $122.63 | General |
| Category: Oncology | ||||||
| 06/02/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $117.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/26/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $35.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/19/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $92.00 | General |
| Category: DIABETES | ||||||
| 04/29/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/02/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $91.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/01/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/28/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $119.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $112.12 | General |
| Category: DIABETES | ||||||
| 07/13/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $88.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/29/2021 | NuVasive, Inc. | RELINE (Device) | Food and Beverage | In-kind items and services | $46.72 | General |
| Category: Spine/Spine Surgery | ||||||
| 03/06/2020 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HBV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 16 | 40 | $6,800 | $3,600 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 40 | $6,800 | $3,600 | 52.9% |
About Dr. Hai Le, M.D
Dr. Hai Le, M.D is a Internal Medicine healthcare provider based in Irvine, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083804801.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hai Le, M.D has received a total of $3,679 in payments from pharmaceutical and medical device companies, with $801.08 received in 2024. These payments were reported across 42 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($3,679).
As a Medicare-enrolled provider, Le has provided services to 16 Medicare beneficiaries, totaling 40 services with total Medicare billing of $3,600. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Irvine, CA
- Active Since 07/27/2007
- Last Updated 12/29/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083804801
Products in Payments
- XARELTO (Drug) $939.29
- DARZALEX (Biological) $560.34
- ELIQUIS (Drug) $438.87
- IMBRUVICA (Drug) $256.88
- JARDIANCE (Drug) $204.12
- TALVEY (Biological) $149.05
- Vemlidy (Drug) $125.00
- VOQUEZNA (Drug) $124.56
- AUSTEDO (Drug) $124.23
- ENTRESTO (Drug) $123.04
- Repatha (Biological) $120.06
- UTIBRON (Drug) $113.97
- VYNDAQEL (Drug) $109.75
- INVEGA SUSTENNA (Drug) $98.13
- FLOWTRIEVER CATHETER, S (Device) $92.78
- RELINE (Device) $46.72
- Nucynta (Drug) $24.17
- JANUVIA (Drug) $17.21
- ZOSTAVAX (Biological) $10.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Irvine
Dr. Tung Ngo, Do, DO
Internal Medicine — Payments: $4.9M
Rashmi Kumar, Md, MD
Internal Medicine — Payments: $121,958
Dr. Irene Kang, M.d, M.D
Internal Medicine — Payments: $55,000
Dr. Behdad Akbarpour, Md, MD
Internal Medicine — Payments: $34,097
Dr. Maher Kassis, M.d, M.D
Internal Medicine — Payments: $30,310
Dr. Shanta Chawla, Md, MD
Internal Medicine — Payments: $17,484